Article
Analysis of the mutation to forskolin-resistance in Y1 adrenocortical tumor cells.
Endocrine research - 1 Jan 2000
Schimmer B P, Tsao J, Collie G, Wong M, Schulz P
Abstract excerpt
Forskolin reduced the plating efficiency of Y1 adrenocortical tumor cells in a concentration-dependent manner--more than 5-orders of magnitude at 10 uM forskolin and at least 6-orders of magnitude at 50 uM forskolin. This effect was related to the diterpene's ability to increase adenylate cyclase activity and adenosine 3',5'-monophosphate (cAMP) levels in Y1 cells. Stable, forskolin-resistant mutants were...
Topics
- Adenylyl Cyclases
- Adrenal Cortex Neoplasms
- Adrenocorticotropic Hormone
- Animals
- Cell Line
- Colforsin
- Cyclic AMP
- Diterpenes
- Drug Resistance
- Mice
- Mutation
